Boire et al. reported that lung and breast cancer cell derived complement component 3 (C3) activated the C3a receptor in the choroid plexus epithelium to disrupt the blood-CSF barrier and interruption of C3a receptor signaling blocks LM in mice16. Here, C3 is linked to breast carcinoma.